Skip to main content

Advertisement

Log in

GLUT1 Variants for Predicting Prognosis After Surgery in Non-small Cell Lung Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.

    Article  PubMed  Google Scholar 

  2. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703–7.

    Article  CAS  PubMed  Google Scholar 

  3. Do SK, Jeong JY, Lee SY, et al. Glucose transporter 1 gene variants predict the prognosis of patients with early-stage non-small cell lung cancer. Ann Surg Oncol. 2018;25:3396–3403.

    Article  PubMed  Google Scholar 

  4. Goodwin J, Neugent ML, Lee SY, et al. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat. Commun. 2017;8:15503.

    Article  CAS  Google Scholar 

  5. Lee SY, Jin CC, Choi JE, et al. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer. Sci Rep. 2016;6:35603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shin Yup Lee MD, PhD or Jae Yong Park MD, PhD.

Ethics declarations

Disclosure

Shin Yup Lee and Jae Yong Park have no conflicts of interest to disclose.

Additional information

ASO Author Reflections is a brief invited commentary on the article, Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-Small Cell Lung Cancer. Ann Surg Oncol. 2018;25:3396–3403.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, S.Y., Park, J.Y. GLUT1 Variants for Predicting Prognosis After Surgery in Non-small Cell Lung Cancer. Ann Surg Oncol 25 (Suppl 3), 948–949 (2018). https://doi.org/10.1245/s10434-018-6847-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6847-1

Keywords

Navigation